These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7242846)
1. The pathology of multiple sclerosis--fact, fiction and hypothesis. Allen IV Neuropathol Appl Neurobiol; 1981; 7(3):169-82. PubMed ID: 7242846 [No Abstract] [Full Text] [Related]
2. Pathology and etiology in multiple sclerosis: a review. Kraft AM; Wessman HC Phys Ther; 1974 Jul; 54(7):716-20. PubMed ID: 4608763 [No Abstract] [Full Text] [Related]
4. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis. Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571 [TBL] [Abstract][Full Text] [Related]
5. Pathology of measles virus infection of the nervous system: comparison with multiple sclerosis. Dubois-Dalcq M Int Rev Exp Pathol; 1979; 19():101-35. PubMed ID: 110718 [No Abstract] [Full Text] [Related]
6. Inflammation, demyelination, and degeneration - recent insights from MS pathology. Stadelmann C; Wegner C; Brück W Biochim Biophys Acta; 2011 Feb; 1812(2):275-82. PubMed ID: 20637864 [TBL] [Abstract][Full Text] [Related]
7. [Pathology of multiple sclerosis]. Shirabe T Nihon Rinsho; 2003 Aug; 61(8):1280-3. PubMed ID: 12962012 [No Abstract] [Full Text] [Related]
8. [Clinical subtypes of multiple sclerosis and the immuno-pathogeneses]. Fujihara K Nihon Rinsho; 2003 Aug; 61(8):1293-9. PubMed ID: 12962014 [TBL] [Abstract][Full Text] [Related]
13. The pathology of multiple sclerosis. Lucchinetti CF; Parisi J; Bruck W Neurol Clin; 2005 Feb; 23(1):77-105, vi. PubMed ID: 15661089 [No Abstract] [Full Text] [Related]
14. Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosis. De Keyser J; Laureys G; Demol F; Wilczak N; Mostert J; Clinckers R Neurochem Int; 2010 Nov; 57(4):446-50. PubMed ID: 20178822 [TBL] [Abstract][Full Text] [Related]
15. Other demyelinating diseases. Tselis AC; Lisak RP Adv Neurol; 2006; 98():335-49. PubMed ID: 16400843 [No Abstract] [Full Text] [Related]
16. Pathology of multiple sclerosis and related inflammatory demyelinating diseases. Kutzelnigg A; Lassmann H Handb Clin Neurol; 2014; 122():15-58. PubMed ID: 24507512 [TBL] [Abstract][Full Text] [Related]
17. Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Steinman L Neuron; 1999 Nov; 24(3):511-4. PubMed ID: 10595504 [No Abstract] [Full Text] [Related]
18. Importance of anatomical features in unravelling mechanisms of demyelination. Colover J Lancet; 1985 May; 1(8439):1214-5. PubMed ID: 2860411 [No Abstract] [Full Text] [Related]
19. Mechanisms of demyelination and tissue damage in multiple sclerosis. Lassmann H Acta Neurol Belg; 1999 Mar; 99(1):6-10. PubMed ID: 10218087 [TBL] [Abstract][Full Text] [Related]